SPAK inhibitor ZT‐1a attenuates reactive astrogliosis and oligodendrocyte degeneration in a mouse model of vascular dementia.

MLA

Bhuiyan, Mohammad Iqbal H., et al. “SPAK Inhibitor ZT‐1a Attenuates Reactive Astrogliosis and Oligodendrocyte Degeneration in a Mouse Model of Vascular Dementia.” CNS Neuroscience & Therapeutics, vol. 30, no. 3, Mar. 2024, pp. 1–15. EBSCOhost, https://doi.org/10.1111/cns.14654.

APA

Bhuiyan, M. I. H., Habib, K., Sultan, M. T., Chen, F., Jahan, I., Weng, Z., Rahman, M. S., Islam, R., Foley, L. M., Hitchens, T. K., Deng, X., Canna, S. W., Sun, D., & Cao, G. (2024). SPAK inhibitor ZT‐1a attenuates reactive astrogliosis and oligodendrocyte degeneration in a mouse model of vascular dementia. CNS Neuroscience & Therapeutics, 30(3), 1–15. https://doi.org/10.1111/cns.14654

Chicago

Bhuiyan, Mohammad Iqbal H., Khadija Habib, Md Tipu Sultan, Fenghua Chen, Israt Jahan, Zhongfang Weng, Md Shamim Rahman, et al. 2024. “SPAK Inhibitor ZT‐1a Attenuates Reactive Astrogliosis and Oligodendrocyte Degeneration in a Mouse Model of Vascular Dementia.” CNS Neuroscience & Therapeutics 30 (3): 1–15. doi:10.1111/cns.14654.